Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Details)

v3.24.0.1
STOCKHOLDERS’ EQUITY (Details)
$ / shares in Units, shares in Millions
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2021
USD ($)
Aug. 06, 2021
USD ($)
$ / shares
shares
Mar. 31, 2018
shares
Dec. 31, 2023
USD ($)
Mar. 31, 2021
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Dec. 30, 2022
USD ($)
Mar. 12, 2021
USD ($)
Apr. 29, 2020
USD ($)
$ / shares
shares
Class of Stock [Line Items]                      
Proceeds from warrant exercise           $ 0 $ 0 $ 8,177,000      
Conversion ratio           1          
2020 Term Loan | Senior Notes                      
Class of Stock [Line Items]                      
Number of shares for purchase under warrant (in shares) | shares                     20.0
Common stock purchase price (in dollars per share) | $ / shares                     $ 1.542
Fair value of warrant                     $ 16,100,000
2019 Term Loan | Loans Payable                      
Class of Stock [Line Items]                      
Number of shares for purchase under warrant (in shares) | shares         6.0            
Fair value of warrant                   $ 6,300,000  
Proceeds from warrant exercise         $ 8,200,000            
Convertible Preferred Stock                      
Class of Stock [Line Items]                      
Sale of stock, number of shares issued in transaction (in shares) | shares     6.1                
New At-the-Market Equity Offering Program                      
Class of Stock [Line Items]                      
Sale of stock, number of shares issued in transaction (in shares) | shares           135.8 67.7        
Proceeds from sale of common stock, net of fees and commissions       $ 40,200,000   $ 112,100,000 $ 299,700,000        
Sale of stock, authorized aggregate sales proceeds amount                 $ 500,000,000    
Equity Offering In Aug 2021 | Common Stock                      
Class of Stock [Line Items]                      
Sale of stock, number of shares issued in transaction (in shares) | shares   35.0                  
Proceeds from sale of common stock, net of fees and commissions   $ 100,800,000                  
Sale of stock, offering price (in USD per share) | $ / shares   $ 3.00                  
Option to purchase additional shares (in shares)   $ 5,300,000                  
Option to purchase additional shares, period   30 days                  
Over-allotment option | Common Stock                      
Class of Stock [Line Items]                      
Proceeds from sale of common stock, net of fees and commissions $ 15,100,000